| Browse All

Mangoceuticals, Inc. (MGRX)

Healthcare | Health Information Services | Dallas, United States | NasdaqCM
0.44 USD -0.04 (-7.419%) ⇩ (April 17, 2026, 4 p.m. EDT)
After hours: 0.46 +0.02 (5.023%) ⇧ (April 17, 2026, 6:27 p.m. EDT)

Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 18, 2026, 11:32 p.m. EDT

MGRX presents a high-risk speculative play with deteriorating fundamentals and a strong short-term bearish forecast, despite recent promotional news; the statistical model predicts a significant 31% price decline over the next 45 days.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.269376
MSTL0.386758
AutoARIMA0.439270
AutoETS0.446518

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 52%
H-stat 3.34
Ljung-Box p 0.000
Jarque-Bera p 0.198
Excess Kurtosis -1.29
Attribute Value
Sector Healthcare
Debt to Equity Ratio 2.025
Revenue per Share 0.045
Market Cap 7,431,730
Beta 2.55
Website https://www.mangoceuticals.com

Info Dump

Attribute Value
52 Week Change -0.8240964
Address1 15,110 N. Dallas Parkway
Address2 Suite 600
All Time High 65.55
All Time Low 0.162
Ask 0.5709
Ask Size 2
Average Daily Volume10 Day 806,450
Average Daily Volume3 Month 12,546,167
Average Volume 12,546,167
Average Volume10Days 806,450
Beta 2.547
Bid 0.3174
Bid Size 2
Book Value 1.133
City Dallas
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.438
Current Ratio 1.738
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 0.4702
Day Low 0.4319
Debt To Equity 2.025
Display Name Mangoceuticals
Ebitda -15,869,579
Ebitda Margins 0.0
Enterprise To Ebitda -0.394
Enterprise To Revenue 13.709
Enterprise Value 6,251,771
Eps Trailing Twelve Months -2.17
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 0.39308
Fifty Day Average Change 0.044919997
Fifty Day Average Change Percent 0.11427699
Fifty Two Week Change Percent -82.40964
Fifty Two Week High 2.875
Fifty Two Week High Change -2.437
Fifty Two Week High Change Percent -0.8476522
Fifty Two Week Low 0.162
Fifty Two Week Low Change 0.276
Fifty Two Week Low Change Percent 1.7037036
Fifty Two Week Range 0.162 - 2.875
Financial Currency USD
First Trade Date Milliseconds 1,679,405,400,000
Float Shares 11,693,607
Free Cashflow 1,876,456
Full Exchange Name NasdaqCM
Full Time Employees 3
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.54907
Gross Profits 250,386
Has Pre Post Market Data 1
Held Percent Insiders 0.10019
Held Percent Institutions 0.14958
Implied Shares Outstanding 16,967,420
Industry Health Information Services
Industry Disp Health Information Services
Industry Key health-information-services
Ipo Expected Date 2,023-03-21
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,729,036,800
Last Split Factor 1:15
Long Business Summary Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. The company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
Long Name Mangoceuticals, Inc.
Market us_market
Market Cap 7,431,730
Market State CLOSED
Max Age 86,400
Message Board Id finmb_1787930606
Most Recent Quarter 1,767,139,200
Net Income To Common -21,818,994
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 7,431,729
Open 0.462
Operating Cashflow -5,850,255
Operating Margins -15.764
Payout Ratio 0.0
Phone 214 242 9619
Post Market Change 0.022000015
Post Market Change Percent 5.0228343
Post Market Price 0.46
Post Market Time 1,776,464,839
Previous Close 0.4731
Price Hint 4
Price To Book 0.38658428
Price To Sales Trailing12 Months 16.296904
Profit Margins 0.0
Quick Ratio 1.669
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.0351
Regular Market Change Percent -7.41915
Regular Market Day High 0.4702
Regular Market Day Low 0.4319
Regular Market Day Range 0.4319 - 0.4702
Regular Market Open 0.462
Regular Market Previous Close 0.4731
Regular Market Price 0.438
Regular Market Time 1,776,456,000
Regular Market Volume 513,120
Return On Assets -0.69905
Return On Equity -1.4166499
Revenue Growth -0.103
Revenue Per Share 0.045
Sand P52 Week Change 0.38150132
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 16,967,420
Shares Percent Shares Out 0.059899997
Shares Short 1,016,081
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 1,737,241
Short Name Mangoceuticals, Inc.
Short Percent Of Float 0.066700004
Short Ratio 0.06
Source Interval 15
State TX
Symbol MGRX
Total Cash 1,486,338
Total Cash Per Share 0.088
Total Debt 307,823
Total Revenue 456,021
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -2.17
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 1.27651
Two Hundred Day Average Change -0.83851004
Two Hundred Day Average Change Percent -0.656877
Type Disp Equity
Volume 513,120
Website https://www.mangoceuticals.com
Zip 75,248